Atlas Trials

A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients

Clinical trial NCT04629404 · COMPLETED

Trial details

NCT number
NCT04629404
Sponsor
Luye Pharma Group Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2018-11-05
Primary completion
2019-03-14
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.